Sunshine Biopharma gets Canadian approval for enalapril
Sunshine Biopharma (SBFM) says it received Canadian regulatory approval for enalapril, positioning the company to expand within a stated $25.94 billion global anti-hypertensive drug market.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.